课题基金 / 基金详情

Basic and developmental research of a novel anti-tumor protein with dendritic cell-inducible activity.

Basic and developmental research of a novel anti-tumor protein with dendritic cell-inducible activity.
具有树突状细胞诱导活性的新型抗肿瘤蛋白的基础和开发研究。
批准号:
21390441
负责人:
NASU Yasutomo
金额:
$9.15万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2011

项目摘要

项目成果

NASU Yasutomo的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The REIC/Dkk-3 gene has been reported to be a tumor suppressor and the expression is significantly downregulated in a broad range of cancer cell types. In this study, we focused the REIC protein and clarified the immunological anti-cancer function and the possible utility for the clinical use. We believe that current findings are available to create innovative cancer-targeting and immunological therapy for the cancer diseases including prostate cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.18926/amo/48076
发表时间: 2012-03
期刊: Acta medica Okayama
影响因子: 0.5
作者: [Keiichiro Kawauchi;Masami Watanabe;H. Kaku;Peng Huang;Kasumi Sasaki;M. Sakaguchi;K. Ochiai;N. Huh;Y. Nasu;H. Kumon]
通讯作者: Keiichiro Kawauchi;Masami Watanabe;H. Kaku;Peng Huang;Kasumi Sasaki;M. Sakaguchi;K. Ochiai;N. Huh;Y. Nasu;H. Kumon
DOI: --
发表时间: 2011-10
期刊: Acta medica Okayama
影响因子: 0.5
作者: [Lei Wang;H. Kaku;P. Huang;Kexin Xu;Kai-Ying Yang;Jiheng Zhang;Ming Li;Liping Xie;Xiao-feng Wang;Akiko Sakai;Masami Watanabe;Y. Nasu;K. Shimizu;H. Kumon;Y. Na]
通讯作者: Lei Wang;H. Kaku;P. Huang;Kexin Xu;Kai-Ying Yang;Jiheng Zhang;Ming Li;Liping Xie;Xiao-feng Wang;Akiko Sakai;Masami Watanabe;Y. Nasu;K. Shimizu;H. Kumon;Y. Na
A randomized phase II traial of personalized peptide vaccine plus low dose estramustin phosphate (EMP) versus standard dose EMP in patients with castration resistant prostate cancer
个性化肽疫苗联合低剂量雌莫司汀磷酸盐 (EMP) 与标准剂量 EMP 在去势抵抗性前列腺癌患者中的随机 II 期试验
DOI: --
发表时间: 2010
期刊: Cancer Immunol Immunother
影响因子: --
作者: [Noguchi M, et al]
通讯作者: et al
DOI: 10.1007/s10147-011-0350-z
发表时间: 2013-02-01
期刊: INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
影响因子: 3.3
作者: [Bekku, Kensuke, Saika, Takashi, Kumon, Hiromi]
通讯作者: Kumon, Hiromi
19
    A novel therapeutic strategy for prostate cancer treatment with anti-cancer immunological proteins.
    • 批准号:
      24390368
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.57万
    • 财政年份:
      2012
    • 负责人:
      NASU Yasutomo
    • 依托单位:
    Fundamental research for new molecular mechanism of anticancer resistance in urogenital cancer
    • 批准号:
      18390437
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.04万
    • 财政年份:
      2006
    • 负责人:
      NASU Yasutomo
    • 依托单位:
    Research on Functional Analysis and Clinical application of New Tumor-associated Gene (REIC) in Urogenital Cancer
    • 批准号:
      15390491
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.43万
    • 财政年份:
      2003
    • 负责人:
      NASU Yasutomo
    • 依托单位:
    Basic and clinical Research for Caveolin as a therapeutic target for urogenital cancer
    • 批准号:
      13671652
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2001
    • 负责人:
      NASU Yasutomo
    • 依托单位:
    海外基金